Trivalent Salmonella Conjugate Vaccine (TSCV)
Showing 1 - 25 of 8,469
Trivalent Salmonella Conjugate Vaccine (TSCV) Trial (TSCV (Full-strength), TSCV (Half-strength), Typbar-TCV)
Not yet recruiting
- Trivalent Salmonella Conjugate Vaccine (TSCV)
- TSCV (Full-strength)
- +3 more
- (no location specified)
Mar 24, 2023
Salmonella Infections Trial (biological, combination product, drug, other)
Not yet recruiting
- Salmonella Infections
- Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose
- +10 more
- (no location specified)
Jul 27, 2022
Typhoid Fever Trial (TYP04A Low Dose without adjuvant investigational vaccine, TYP04B Full Dose without adjuvant investigational
Not yet recruiting
- Typhoid Fever
- TYP04A Low Dose without adjuvant investigational vaccine
- +5 more
- (no location specified)
Nov 4, 2022
Risk Reduction Trial in Baltimore (Trivalent Invasive Salmonella Disease Vaccine (6.25 µg), Trivalent Invasive Salmonella
Completed
- Risk Reduction
- Trivalent Invasive Salmonella Disease Vaccine (6.25 µg)
- +4 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
Oct 25, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (biological, drug, other)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 24, 2022
Typhoid Conjugate Vaccine Introduction in Navi Mumbai, India
Completed
- Enteric Fever
- +2 more
- Typhoid Conjugate Vaccine
-
Navi Mumbai, India
- +5 more
Sep 30, 2021
Plasma Cell Tumor Trial in Atlanta (Pneumococcal 13-valent Conjugate Vaccine, Trivalent Influenza Vaccine)
Active, not recruiting
- Plasma Cell Neoplasm
- Pneumococcal 13-valent Conjugate Vaccine
- Trivalent Influenza Vaccine
-
Atlanta, Georgia
- +1 more
Jan 24, 2022
Relapsed Neuroblastoma Trial in Minsk (DNA vaccine, Salmonella oral vaccine, Lenalidomide)
Recruiting
- Relapsed Neuroblastoma
- DNA vaccine
- +2 more
-
Minsk, Minsk Region, BelarusBelarussian Research Center for Pediatric Oncology, Hematology a
Mar 1, 2022
Typhoid Trial in Dhaka (Typhoid Vi polysaccharide-diphtheria toxoid conjugate vaccine (Vi-DT))
Not yet recruiting
- Typhoid
- Typhoid Vi polysaccharide-diphtheria toxoid conjugate vaccine (Vi-DT)
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research, Bangladesh
Jul 25, 2022
Healthy Trial in Dasmarinas, Manila (sIPV, cIPV)
Completed
- Healthy
- sIPV
- cIPV
-
Dasmarinas, Philippines
- +2 more
Aug 6, 2020
Typhoid Fever Trial in Kisantu (Vi-TT)
Not yet recruiting
- Typhoid Fever
- Vi-TT
-
Kisantu, Congo, The Democratic Republic of theHôpital Saint Luc de Kisantu
Nov 12, 2021
Epidemic Meningitis Trial (MCV4)
Not yet recruiting
- Epidemic Meningitis
- MCV4
- (no location specified)
Jul 5, 2023
COVID-19 Trial in Manila, Putatan (SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for
Not yet recruiting
- COVID-19
- SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
- SCB-2019 (monovalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
-
Manila, Philippines
- +2 more
Jun 21, 2023
COVID-19 Trial in Chengdu (LYB002V14, LYB002V14A, LYB002CA)
Active, not recruiting
- COVID-19
- LYB002V14
- +2 more
-
Chengdu, Sichuan, ChinaAffiliated Hospital of North Sichuan MedicalCollege
Jun 29, 2023
COVID-19 Trial (High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), Low dose of Recombinant
Not yet recruiting
- COVID-19
- High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell)
- +3 more
- (no location specified)
Jun 19, 2023
Pneumococcal Vaccines Trial in Canada (IVT PCV-25 Formulation A, IVT PCV-25 Formulation B, IVT PCV-25 Formulation C)
Not yet recruiting
- Pneumococcal Vaccines
- IVT PCV-25 Formulation A
- +3 more
-
Vancouver, British Columbia, Canada
- +3 more
Oct 10, 2023
Meningococcal Infection (Healthy Volunteers) Trial in Middelburg (Meningococcal Polysaccharide (Serogroups A, C, Y, and W)
Recruiting
- Meningococcal Infection (Healthy Volunteers)
- Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
- +11 more
-
Middelburg, South AfricaInvestigational Site Number: 7100001
Apr 4, 2023
Infants' Family Decide Baby's Vaccine Trial (Patients Decision Aids (PDA))
Not yet recruiting
- Infants' Family Decide Baby's Vaccine
- Patients Decision Aids (PDA)
- (no location specified)
Oct 10, 2022
Pneumococcal Infection Trial (V116, Placebo for PCV15 + PPSV23, PCV15)
Not yet recruiting
- Pneumococcal Infection
- V116
- +3 more
- (no location specified)
Jan 13, 2023
Streptococcus Pneumoniae Infection Trial in China (13-valent pneumococcal conjugate vaccine (multivalent conjugate), Prevenar
Recruiting
- Streptococcus Pneumoniae Infection
- 13-valent pneumococcal conjugate vaccine (multivalent conjugate)
- Prevenar 13
-
Hechi City, Guangxi Zhuang Autonomous Region, China
- +4 more
Feb 26, 2023
Healthy Volunteers (Meningococcal Infection) Trial in Puerto Rico, United States (Meningococcal Polysaccharide (Serogroups A,C,Y
Recruiting
- Healthy Volunteers (Meningococcal Infection)
- Meningococcal Polysaccharide (Serogroups A,C,Y and W) Tetanus Toxoid Conjugate vaccine MenACYW conjugate vaccine
- +10 more
-
Birmingham, Alabama
- +50 more
Jan 4, 2023
Rotavirus Infections, Rotavirus Gastroenteritis Trial in Shangqiu (Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine,
Recruiting
- Rotavirus Infections
- Rotavirus Gastroenteritis
- Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine
- +2 more
-
Shangqiu, Henan, China
- +1 more
Jan 31, 2023
Meningitis, Meningococcal Meningitis, Meningococcal Infections Trial in Puerto Rico, United States (Meningococcal Polysaccharide
Completed
- Meningitis
- +2 more
- Meningococcal Polysaccharide (Serogroups A, C, Y, and W135) Tetanus Toxoid Conjugate Vaccine
- +3 more
-
Birmingham, Alabama
- +35 more
Mar 24, 2022
Meningococcal Meningitis Trial in Surabaya (batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4), batch 2 of
Not yet recruiting
- Meningococcal Meningitis
- batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
- +3 more
-
Surabaya, IndonesiaHusada Utama Hospital
Nov 13, 2023
Pneumococcal Disease Trial in Worldwide (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)
Active, not recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
-
Nedlands, Western Australia, Australia
- +63 more
Nov 3, 2022